March 21, 2022
Mayo Clinic discovery in bone marrow cancer points to potential drug targets
By Susan Murphy
New research from Mayo Clinic’s Center for Individualized Medicine finds that patients with ASXL1-mutant chronic myelomonocytic leukemia — an uncommon type of cancer of the bone marrow — have distinctive epigenetic changes that can activate harmful genes and cause the cancer to grow faster. The ASXL1 genetic mutation also can transform the disease into the more aggressive acute myeloid leukemia. […]
Tags: #acute myeloid leukemia, #chronic myelomonocytic leukemia, center for individualized medicine, genomic medicine, genomics, medical research
August 15, 2019
Shaping the landscape of cancer care with precision therapies
By Sharon Rosen
Article by Sara Damore Jeffrey Tyner, Ph.D., associate professor in the Department of Cell & Developmental Biology at Oregon Health & Science University, will join several precision cancer care leaders from across the country at the annual Individualizing Medicine Conference. Dr. Tyner will present “Precision Therapy through Functional Genomics in Hematologic Malignancies.” Dr. Tyner’s research […]
Tags: #acute myeloid leukemia, #CIMCon19, #Dr. Jeffrey Tyner, #Functional Genomics, #targeted therapies, blood cancers, center for individualized medicine, genomics, hematolgic malignancies, Individualizing Medicine Conference 2019, mayo clinic, Oregon Health and Science University